WO2003093300A3 - Peptides anti-microbiens et compositions - Google Patents

Peptides anti-microbiens et compositions Download PDF

Info

Publication number
WO2003093300A3
WO2003093300A3 PCT/US2003/014240 US0314240W WO03093300A3 WO 2003093300 A3 WO2003093300 A3 WO 2003093300A3 US 0314240 W US0314240 W US 0314240W WO 03093300 A3 WO03093300 A3 WO 03093300A3
Authority
WO
WIPO (PCT)
Prior art keywords
compositions
microbial peptides
cyclic peptides
acids
peptides
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
PCT/US2003/014240
Other languages
English (en)
Other versions
WO2003093300A2 (fr
Inventor
M Reza Ghadiri
Hui Sun Kim
Sara Fernandez-Lopez
Keith Wilcoxen
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Scripps Research Institute
Original Assignee
Scripps Research Institute
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from PCT/US2002/014329 external-priority patent/WO2002090503A2/fr
Application filed by Scripps Research Institute filed Critical Scripps Research Institute
Priority to AU2003228896A priority Critical patent/AU2003228896A1/en
Publication of WO2003093300A2 publication Critical patent/WO2003093300A2/fr
Publication of WO2003093300A3 publication Critical patent/WO2003093300A3/fr
Anticipated expiration legal-status Critical
Ceased legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K7/00—Peptides having 5 to 20 amino acids in a fully defined sequence; Derivatives thereof
    • C07K7/64—Cyclic peptides containing only normal peptide links
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K7/00—Peptides having 5 to 20 amino acids in a fully defined sequence; Derivatives thereof
    • C07K7/50—Cyclic peptides containing at least one abnormal peptide link
    • C07K7/54—Cyclic peptides containing at least one abnormal peptide link with at least one abnormal peptide link in the ring
    • C07K7/56—Cyclic peptides containing at least one abnormal peptide link with at least one abnormal peptide link in the ring the cyclisation not occurring through 2,4-diamino-butanoic acid
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
    • Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
    • Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Genetics & Genomics (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • General Health & Medical Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)

Abstract

La présente invention concerne de nouveaux agents anti-microbiens et des compositions qui incluent des peptides cycliques portant une séquence d'acides aminés faisant alterner les acides aminés L et D. Selon un autre mode de réalisation, les peptides cycliques sont faits d'acides aminés β.
PCT/US2003/014240 2002-05-06 2003-05-06 Peptides anti-microbiens et compositions Ceased WO2003093300A2 (fr)

Priority Applications (1)

Application Number Priority Date Filing Date Title
AU2003228896A AU2003228896A1 (en) 2002-05-06 2003-05-06 Anti-microbial peptides and compositions

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
USPCT/US02/14329 2002-05-06
PCT/US2002/014329 WO2002090503A2 (fr) 2001-05-04 2002-05-06 Peptides antimicrobiens et compositions

Publications (2)

Publication Number Publication Date
WO2003093300A2 WO2003093300A2 (fr) 2003-11-13
WO2003093300A3 true WO2003093300A3 (fr) 2004-09-10

Family

ID=29398926

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/US2003/014240 Ceased WO2003093300A2 (fr) 2002-05-06 2003-05-06 Peptides anti-microbiens et compositions

Country Status (2)

Country Link
AU (1) AU2003228896A1 (fr)
WO (1) WO2003093300A2 (fr)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7566765B2 (en) 2000-03-06 2009-07-28 Rigel Pharmaceuticals, Inc. Heterocyclic compounds containing a nine-membered carbon-nitrogen ring
US7851457B2 (en) 2004-01-29 2010-12-14 Innovative Biologics, Inc. β-Cyclodextrin derivatives
US20080234182A1 (en) * 2007-03-22 2008-09-25 Innovative Biologics, Inc. Blockers of pore-forming virulence factors and their use as anti-infectives
KR101413746B1 (ko) * 2005-12-22 2014-07-01 노바바이오틱스 리미티드 고리형 항균 펩타이드
AU2012203804B2 (en) * 2005-12-22 2014-10-16 Novabiotics Limited Cyclic antimicrobial peptides
WO2010051667A1 (fr) * 2008-11-10 2010-05-14 复旦大学 Compositions pharmaceutiques comprenant des nanotubes de peptide cyclique et utilisations de celles-ci

Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1995010535A1 (fr) * 1993-10-14 1995-04-20 The Scripps Research Institute Tube peptidique cyclique

Patent Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1995010535A1 (fr) * 1993-10-14 1995-04-20 The Scripps Research Institute Tube peptidique cyclique

Non-Patent Citations (3)

* Cited by examiner, † Cited by third party
Title
FERNANDEZ-LOPEZ, ET AL: "ANTIBACTERIAL AGENTS BASED ON THE CYCLIC D,L-ALPHA-PEPTIDE ARCHITECTURE", NATURE, vol. 412, no. 6845, 26 July 2001 (2001-07-26), pages 452 - 455, XP002971654 *
GHADLRI, ET AL: "SELF-ASSEMBLING ORGANIC NANOTUBES BASED ON A CYCLIC PEPTIDE ARCHITECTURE", NATURE, vol. 366, 25 November 1993 (1993-11-25), pages 324 - 327, XP002936460 *
RAPAPORT, ET AL: "CRYSTALLINE CYCLIC PEPTIDE NANOTUBES AT INTERFACE", J. AM. CHEM. SOC., vol. 121, 1999, pages 1186 - 1191, XP002971655 *

Also Published As

Publication number Publication date
AU2003228896A1 (en) 2003-11-17
AU2003228896A8 (en) 2003-11-17
WO2003093300A2 (fr) 2003-11-13

Similar Documents

Publication Publication Date Title
WO2002090503A3 (fr) Peptides antimicrobiens et compositions
CY1107146T1 (el) Μεθοδοι για προληψη και θεραπεια ασθενειας alzheimer (ad)
WO2003011115A3 (fr) Agents de contraste multimères ciblés à base de peptides
IL232501A (en) Peptide or polypeptide-resistant protein analogs and their uses
AU2002217010A1 (en) Peptides, the production and use thereof for binding immunoglobulins
EP2204189A3 (fr) Fragments de peptides d'allergène et leur utilisation
DE60235761D1 (de) Isoform des vegfs
ATE551048T1 (de) Proteinhydrolysate enthaltende kosmetische zusammensetzungen
WO2003031598A3 (fr) Sequences d'acides nucleiques et d'acides amines codant des polypeptides de facteur viii a expresseur a haut rendement et leurs procedes d'utilisation
WO2003048205A3 (fr) Proteines a activite inhibitrice de l'il-6
WO2005059131A3 (fr) Proteine fixant des proteines en miniature et leurs applications
WO2004087073A3 (fr) Traitement d'etats de demyelinisation
DE50305507D1 (de) Zusammensetzungen zur herstellung von aminoplasterzeugnissen
WO2003093300A3 (fr) Peptides anti-microbiens et compositions
WO2004050685A3 (fr) Agents therapeutiques antifongiques
WO2004019965A3 (fr) Approches tolerogenes a base de thymus destinees au diabete de type i.
WO2005074626A3 (fr) Compositions, procedes et utilisations associes a une nouvelle famille de peptides
WO2005037236A3 (fr) Nouveaux polypeptides associes a la proteine de choc thermique 20 et utilisations
EP1978994A4 (fr) Compositions à base de variantes de bmp-7, procédés et utilisations
SG142165A1 (en) Biologically active peptides
SG146640A1 (en) Isolated photoprotein mtclytin, and use thereof
DE60329115D1 (de) Tumorantigenprotein und dessen verwendung
MXPA05012742A (es) Composiciones de tratamiento para el cabello.
WO2007110772A8 (fr) Oligopeptides immunomodulateurs
WO2006090090A3 (fr) Epitopes de vih et composition pharmaceutique les contenant

Legal Events

Date Code Title Description
AK Designated states

Kind code of ref document: A2

Designated state(s): AE AG AL AM AT AU AZ BA BB BG BR BY BZ CA CH CN CO CR CU CZ DE DK DM DZ EC EE ES FI GB GD GE GH GM HR HU ID IL IN IS JP KE KG KP KR KZ LC LK LR LS LT LU LV MA MD MG MK MN MW MX MZ NI NO NZ OM PH PL PT RO RU SC SD SE SG SK SL TJ TM TN TR TT TZ UA UG US UZ VC VN YU ZA ZM ZW

AL Designated countries for regional patents

Kind code of ref document: A2

Designated state(s): GH GM KE LS MW MZ SD SL SZ TZ UG ZM ZW AM AZ BY KG KZ MD RU TJ TM AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HU IE IT LU MC NL PT RO SE SI SK TR BF BJ CF CG CI CM GA GN GQ GW ML MR NE SN TD TG

121 Ep: the epo has been informed by wipo that ep was designated in this application
DFPE Request for preliminary examination filed prior to expiration of 19th month from priority date (pct application filed before 20040101)
122 Ep: pct application non-entry in european phase
NENP Non-entry into the national phase

Ref country code: JP

WWW Wipo information: withdrawn in national office

Country of ref document: JP